Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
This section explains why investors might choose an Equal Weighted Index, focusing on balanced exposure and straightforward rebalancing.
22,679 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Trump signals possible U.S. ground action against Mexican cartels, sending ripples through defense stocks and supply ...
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
A targeted international dividend fund surged 26% over the past year and yields around 3.1%, while broad overseas exp...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Bitcoin surged to a 12-day high on news of a peace deal, driving a broad crypto market rally. ZEC and other altcoins ...
Debt financing for AI infrastructure surged almost 100% over the last year, reshaping risk in credit markets. Analyst...
The Roundhill Memory ETF DRAM has surged in 2026, roughly doubling and delivering a year-to-date gain near 100% as AI...
Ethereum rebounds from $1,500 support but faces a critical ceiling near $2,000. Traders will watch the $1.8K–$2K zone...
A batch of midweek analyst notes lifts several big names, steering markets higher as investors weigh price targets, e...
An iconic value investor credits a personality test for steering him from a $6 million revenue business to a legendar...
SpaceX shares declined about 7% after the Federal Reserve kept rates steady, ending a brief three-day rally since its...